Trial Outcomes & Findings for Epi Stim to Facilitate Standing and Stepping (NCT NCT02339233)

NCT ID: NCT02339233

Last Updated: 2022-04-22

Results Overview

We will measure the amount of time individuals are able to stand without manual assistance (independently) throughout a 10 min bout

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

8 participants

Primary outcome timeframe

Baseline, 160 sessions (1 year)

Results posted on

2022-04-22

Participant Flow

Participant milestones

Participant milestones
Measure
Epidural Stimulator
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Overall Study
STARTED
8
Overall Study
COMPLETED
8
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Epidural Stimulator
n=8 Participants
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Age, Categorical
<=18 years
0 Participants
n=8 Participants
Age, Categorical
Between 18 and 65 years
8 Participants
n=8 Participants
Age, Categorical
>=65 years
0 Participants
n=8 Participants
Sex: Female, Male
Female
1 Participants
n=8 Participants
Sex: Female, Male
Male
7 Participants
n=8 Participants

PRIMARY outcome

Timeframe: Baseline, 160 sessions (1 year)

We will measure the amount of time individuals are able to stand without manual assistance (independently) throughout a 10 min bout

Outcome measures

Outcome measures
Measure
Epidural Stimulator
n=8 Participants
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Change From Baseline of Lower Extremity Independence Time During 10 Min Standing Bout After 160 Sessions (1 Year)
40.6 minutes
Standard Deviation 30.2

PRIMARY outcome

Timeframe: Baseline, 160 session (1 year)

We will measure the number of steps individuals are able to take without manual assistance (independently) throughout a 6 min stepping bout

Outcome measures

Outcome measures
Measure
Epidural Stimulator
n=8 Participants
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Change From Baseline of Stepping Independence Time During 6 Min Stepping Bout After 160 Sessions (1 Year)
197.13 steps
Standard Deviation 421.89

SECONDARY outcome

Timeframe: Baseline, 160 sessions (1 year)

We will measure the ability of the individuals to perform consecutive hip flexion repetitions with stimulation during a 1 minute period

Outcome measures

Outcome measures
Measure
Epidural Stimulator
n=8 Participants
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Change From Baseline of Number of Consecutive Hip Flexion Repetitions Performed Within One Minute After 160 Sessions (1 Year)
14.25 Repetitions
Standard Deviation 9.8

Adverse Events

Epidural Stimulator

Serious events: 2 serious events
Other events: 5 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Epidural Stimulator
n=8 participants at risk
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Surgical and medical procedures
Device Malfunction
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.
Musculoskeletal and connective tissue disorders
Hip Fracture
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.

Other adverse events

Other adverse events
Measure
Epidural Stimulator
n=8 participants at risk
Eligible participants will be implanted with 16-electrode epidural array in the T11-L1 area of the spinal cord Standing and Stepping with spinal cord Epidural Stimulation: Standing and Stepping with support from trainers as needed, overground or in a harness with body weight support on a treadmill. Epidural stimulation with specific configurations will be administered to generate standing and stepping.
Musculoskeletal and connective tissue disorders
Muscle Strain
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.
Surgical and medical procedures
Flipped Stimulator
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.
Surgical and medical procedures
Electrode Malfunction
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.
Skin and subcutaneous tissue disorders
Incision Site Drainage
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.
Musculoskeletal and connective tissue disorders
Right Ankle Edema
12.5%
1/8 • Number of events 1 • From implant through the end of the second intervention, an average of one year.

Additional Information

Dr. Susan Harkema

University of Lousiville

Phone: 502-581-8675

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place